Supplementary Material for: An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia After Experiencing Pleural Effusion During Dasatinib Therapy
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22581610
J
John Brokars
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
24
Citations
3
h-index
1
i10-index
John Brokars is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Eosinophilic Disorders and Syndromes. The author has an h-index of 3, co-authored 13 publications.
Papers by this author
worksSupplementary Material for: An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia After Experiencing Pleural Effusion During Dasatinib Therapy
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22581949
Supplementary Material for: An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia After Experiencing Pleural Effusion During Dasatinib Therapy
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22581607
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat